↓ Skip to main content

Update on mesenchymal stem cell-based therapy in lupus and scleroderma

Overview of attention for article published in Arthritis Research & Therapy, November 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Published in
Arthritis Research & Therapy, November 2015
DOI 10.1186/s13075-015-0819-7
Pubmed ID
Authors

Audrey Cras, Dominique Farge, Thierry Carmoi, Jean-Jacques Lataillade, Dan Dan Wang, Lingyun Sun

Abstract

Current systemic therapies are rarely curative for patients with severe life-threatening forms of autoimmune diseases (ADs). During the past 15 years, autologous hematopoietic stem cell transplantation has been demonstrated to cure some patients with severe AD refractory to all other available therapies. As a consequence, ADs such as lupus and scleroderma have become an emerging indication for cell therapy. Multipotent mesenchymal stem cells (MSCs), isolated from bone marrow and other sites, display specific immunomodulation and anti-inflammatory properties and appear as ideal tools to treat such diseases. The present update aims at summarizing recent knowledge acquired in the field of MSC-based therapies for lupus and scleroderma.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United Kingdom 1 <1%
United States 1 <1%
Unknown 105 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 18%
Student > Master 14 13%
Other 13 12%
Student > Ph. D. Student 9 8%
Student > Bachelor 6 6%
Other 16 15%
Unknown 31 29%
Readers by discipline Count As %
Medicine and Dentistry 39 36%
Biochemistry, Genetics and Molecular Biology 9 8%
Immunology and Microbiology 8 7%
Agricultural and Biological Sciences 7 6%
Nursing and Health Professions 4 4%
Other 9 8%
Unknown 32 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2017.
All research outputs
#2,529,971
of 25,374,647 outputs
Outputs from Arthritis Research & Therapy
#500
of 3,381 outputs
Outputs of similar age
#35,283
of 296,420 outputs
Outputs of similar age from Arthritis Research & Therapy
#20
of 99 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,420 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.